Background information and expert insight
Welcome to Alzheimer's Today, a new continuing symposium to help promote research, care, policy and education on topics concerning Alzheimer's and other diseases affecting memory, movement and mood. Alzheimer's Today will showcase key topics and emerging new research trends that ultimately enhance the lives of all those affected by Alzheimer's dementia.
There are three challenges compelling a comprehensive and critical analysis of current ideas about dementia. First, there is a necessity to broaden the spectrum of therapeutic targets. Second, the puzzle of mixed pathologies in differential diagnosis or clinical studies for treatment needs to be solved. And third, there is an urgency to understand the transitions states from non-impairment to diseased.
Unlocking complex, intersecting, and overlapping interactions among risk factors including proteins, genes, and environmental exposures remains a daunting research problem. The application of advanced data analytics offers intriguing possibilities for new therapies, diagnostics and other tools to care for patients.
Global health policy efforts now integrate Alzheimer's disease as a central impetus for broader efforts to address societal challenges associated with the ongoing longevity revolution. These efforts must improve multiple domains of modern society including social pension plans, retirement, housing, healthcare, long–term care, and research.
Insulin is well known as a hormone that regulates blood sugar levels. However, new research is reexamining the role of insulin in the brain: from its potential influence on the development of Alzheimer's disease and other dementias to the possibility for new treatment strategies.
Neuropsychiatric symptoms in Alzheimer's disease are widespread and disabling. Ever since Dr. Alois Alzheimer's first case presented with emotional distress and delusions of infidelity and excessive jealousy, these common features continue to challenge the care and management of patients with Alzheimer's.
Continuing Medical Education activities to educate healthcare professionals about Alzheimer's disease and dementia.